NEW YORK (GenomeWeb News) – Genetic Technologies' fiscal 2013 first-quarter revenues dropped 50 percent year over year, the Australian firm said today in a regulatory document.

For the three months ended Sept. 30, GTG posted A$1.2 million (US$1.2 million) in receipts, down from A$2.4 million a year ago. Its loss for the quarter rose 69 percent to A$2.2 million from A$1.3 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.